Related references
Note: Only part of the references are listed.COVID-19′s Psychological Impact on Chronic Disease Patients Seeking Medical Care
Hager Salah et al.
HEALTHCARE (2023)
Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria
Deborah A. Bilder et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)
Knowledge, perceptions and behaviours regarding dietary management of adults living with phenylketonuria
Sarah J. Firman et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2022)
The impact of COVID-19 on chronic disease management in primary care: lessons for Australia from the international experience
Anne Parkinson et al.
MEDICAL JOURNAL OF AUSTRALIA (2022)
Global impact of COVID-19 on newborn screening programmes
Vanesa Koracin et al.
BMJ GLOBAL HEALTH (2022)
Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuria
Karina Grohmann-Held et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2022)
Country-specific estimates of unintended pregnancy and abortion incidence: a global comparative analysis of levels in 2015-2019
Jonathan Marc Bearak et al.
BMJ GLOBAL HEALTH (2022)
The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers
Alberto Burlina et al.
CURRENT MEDICAL RESEARCH AND OPINION (2021)
Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy
Carmen Rohde et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Newborn screening in latin america: A brief overview of the state of the art
Gustavo J. C. Borrajo
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2021)
Long-Term Neurological Outcomes of Adult Patients with Phenylketonuria before and after Newborn Screening in Japan
Kenji Yamada et al.
INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2021)
Phenylketonuria: Current Treatments and Future Developments
Uta Lichter-Konecki et al.
DRUGS (2019)
The European Phenylketonuria Guidelines and the challenges on management practices in Portugal
Catia Sousa et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2019)
Conceptualizing Childbearing Ambivalence: A Social and Dynamic Perspective
Christie Sennott et al.
JOURNAL OF MARRIAGE AND FAMILY (2018)
Adherence to clinic recommendations among patients with phenylketonuria in the United States
E. R. Jurecki et al.
MOLECULAR GENETICS AND METABOLISM (2017)
The complete European guidelines on phenylketonuria: diagnosis and treatment
A. M. J. van Wegberg et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Key European guidelines for the diagnosis and management of patients with phenylketonuria
Francjan J. van Spronsen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
It just happens: a qualitative study exploring low-income women's perspectives on pregnancy intention and planning
Sonya Borrero et al.
CONTRACEPTION (2015)
Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations
Patricia Fernanda Schuck et al.
AGING AND DISEASE (2015)
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
Jerry Vockley et al.
GENETICS IN MEDICINE (2014)
Blood phenylalanine control in phenylketonuria: a survey of 10 European centres
K. Ahring et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2011)
Phenylalanine hydroxylase deficiency
John J. Mitchell et al.
GENETICS IN MEDICINE (2011)
Dietary management practices in phenylketonuria across European centres
Kirsten Ahring et al.
CLINICAL NUTRITION (2009)